In the original article, there was a mistake in Table [2](#T1){ref-type="table"} as published. The units for C reactive protein, ≥3 g/dL, were incorrect, and in fact, because different laboratories have different normal ranges for C reactive protein, we are not providing a specific value. The corrected Table [2](#T1){ref-type="table"} appears below.

###### 

Proposed working case definition of KSHV inflammatory cytokine syndrome.

  **1. CLINICAL MANIFESTATIONS^\*^**                                                                     
  ------------------------------------------------------------------------------------------------------ -----------------------------------
  **a. Symptoms**                                                                                        **b. Laboratory abnormalities**
  Fever                                                                                                  Anemia
  Fatigue                                                                                                Thrombocytopenia
  Edema                                                                                                  Hypoalbuminemia
  Cachexia                                                                                               Hyponatremia
  Respiratory symptoms (including cough, dyspnea, airway hyperreactivity)                                **c. Radiographic abnormalities**
  Gastrointestinal disturbance (including nausea, anorexia, abdominal discomfort, altered bowel habit)   Lymphadenopathy
  Athralgia and myalgia                                                                                  Splenomegaly
  Altered mental state                                                                                   Hepatomegaly
  Neuropathy with or without pain                                                                        Body cavity effusions
  **2. EVIDENCE OF SYSTEMIC INFLAMMATION**                                                               
  Elevated C-reactive protein                                                                            
  **3. EVIDENCE OF KSHV LYTIC ACTIVITY**                                                                 
  Elevated KSHV viral load in peripheral blood mononuclear cells (≥100 copies/10^6^ cells)               
  **4. NO EVIDENCE OF KSHV-ASSOCIATED MULTICENTRIC cASTLEMAN DISEASE**                                   
  Exclusion of MCD requires pathologic assessment lymph node, bone marrow, or spleen                     

*The working case definition of KICS requires the presence of at least two clinical manifestations drawn from at least two categories (1a, b, and c), together with each of the criteria in 2, 3, and 4. Clinical manifestations for the working definition are drawn from the initial case series and from findings commonly seen in KSHV-MCD*.

In addition, the copyright should be considered inaccurate and has been removed to reflect the policies of the United States Government. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

The original article has been updated.
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